Cairncross JG - Search Results

1

Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms.

Zlatescu MC, TehraniYazdi A, Sasaki H, Megyesi JF, Betensky RA, Louis DN, Cairncross JG. Zlatescu MC, et al. Among authors: cairncross jg. Cancer Res. 2001 Sep 15;61(18):6713-5. Cancer Res. 2001. PMID: 11559541

2

DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis.

Sasaki H, Betensky RA, Cairncross JG, Louis DN. Sasaki H, et al. Among authors: cairncross jg. Cancer Res. 2002 Mar 15;62(6):1790-6. Cancer Res. 2002. PMID: 11912156

3

Imaging correlates of molecular signatures in oligodendrogliomas.

Megyesi JF, Kachur E, Lee DH, Zlatescu MC, Betensky RA, Forsyth PA, Okada Y, Sasaki H, Mizoguchi M, Louis DN, Cairncross JG. Megyesi JF, et al. Among authors: cairncross jg. Clin Cancer Res. 2004 Jul 1;10(13):4303-6. doi: 10.1158/1078-0432.CCR-04-0209. Clin Cancer Res. 2004. PMID: 15240515

4

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN. Cairncross JG, et al. J Natl Cancer Inst. 1998 Oct 7;90(19):1473-9. doi: 10.1093/jnci/90.19.1473. J Natl Cancer Inst. 1998. PMID: 9776413

5

The hPMS2 exon 5 mutation and malignant glioma. Case report.

Taylor MD, Perry J, Zlatescu MC, Stemmer-Rachamimov AO, Ang LC, Ino Y, Schwartz M, Becker LE, Louis DN, Cairncross JG. Taylor MD, et al. Among authors: cairncross jg. J Neurosurg. 1999 May;90(5):946-50. doi: 10.3171/jns.1999.90.5.0946. J Neurosurg. 1999. PMID: 10223463

6

Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.

Bauman GS, Ino Y, Ueki K, Zlatescu MC, Fisher BJ, Macdonald DR, Stitt L, Louis DN, Cairncross JG. Bauman GS, et al. Among authors: cairncross jg. Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):825-30. doi: 10.1016/s0360-3016(00)00703-3. Int J Radiat Oncol Biol Phys. 2000. PMID: 11020580

7

Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.

Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN. Ino Y, et al. Among authors: cairncross jg. Clin Cancer Res. 2001 Apr;7(4):839-45. Clin Cancer Res. 2001. PMID: 11309331

8

Inactivation of p53 sensitizes U87MG glioma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea.

Xu GW, Nutt CL, Zlatescu MC, Keeney M, Chin-Yee I, Cairncross JG. Xu GW, et al. Among authors: cairncross jg. Cancer Res. 2001 May 15;61(10):4155-9. Cancer Res. 2001. PMID: 11358839

9

Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1.

Cahill DP, Louis DN, Cairncross JG. Cahill DP, et al. Among authors: cairncross jg. CNS Oncol. 2015;4(5):287-94. doi: 10.2217/cns.15.32. Epub 2015 Nov 6. CNS Oncol. 2015. PMID: 26545048 Free PMC article. Review.

10

Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma".

Sasaki H, Zlatescu MC, Betensky RA, Johnk LB, Cutone AN, Cairncross JG, Louis DN. Sasaki H, et al. Among authors: cairncross jg. J Neuropathol Exp Neurol. 2002 Jan;61(1):58-63. doi: 10.1093/jnen/61.1.58. J Neuropathol Exp Neurol. 2002. PMID: 11829344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters